Cytotheryx

Rochester, United States

Cytotheryx is a preclinical cell therapy company focused on the development of a consistent, high-quality source of human hepatocytes.

$60.0M raised

Jan 2026

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cytotheryx raised?

Cytotheryx has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Who are Cytotheryx's investors?

Cytotheryx's investors include Ouroboros Family Founders Fund I, QRS Investments.

Where is Cytotheryx headquartered?

Cytotheryx is headquartered in Rochester, United States.

What does Cytotheryx do?

Cytotheryx is a preclinical cell therapy company focused on the development of a consistent, high-quality source of human hepatocytes.

What stage is Cytotheryx at?

Cytotheryx is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 12, 2026.

MLA

"Cytotheryx — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/cytotheryx. Accessed July 2, 2026.

APA

VCBacked. (2026). Cytotheryx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cytotheryx

Wikipedia (cite web)

{{cite web |title=Cytotheryx — Funding & Investors |url=https://www.vcbacked.co/company/cytotheryx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 12, 2026.